Clinical trials - also known as clinical studies or research protocols - are conducted to test whether a new drug, new prevention strategy, or new screening test is safe and effective in people. Participation is always voluntary. ÌÇÐÄÊÓƵ of Medicine investigators conduct hundreds of studies, ranging from small, short-term studies to large trials with thousands of patients across many institutions.
View Actively Recruiting Studies at ÌÇÐÄÊÓƵ of Medicine trials on .
Search for Clinical Trials
S2210: A Phase II Study of Neoadjuvant Carboplatin for Localized, High Risk Prostate Cancer With Germline BRCA1/2 MutationsThis phase II trial…
NRG-BN013: Phase III Trial of Single Fraction Stereotactic Radiosurgery (SRS) Versus Fractionated SRS (FSRS) for Intact Brain MetastasesThis phase…
S2209: A Phase III Randomized Trial for Newly Diagnosed Multiple Myeloma (NDMM) Patients Considered Frail or in a Subset of "Intermediate Fit"…
A Randomized, Open-label, Phase 3 Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Participants With Endometrial Cancer Who…
FORTE (NRG-CC005): Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous PolypsThis trial examines colorectal cancer incidence in…
A Single Arm Phase 4 Trial to Evaluate the Safety and Efficacy of Oral Fruquintinib in the Treatment of Refractory Metastatic Colorectal Cancer in…
A Randomized Phase III Trial of Intravesical BCG veRsus Intravesical Docetaxel and GEmcitabine Treatment in BCG Naïve High Grade Non-Muscle Invasive…
GLOFIT: A Phase Ib Study Evaluating the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Glofitamab in Combination With Gemcitabine Plus…
ROADS Trial: A Phase 3 Randomized Controlled Trial of Post-Surgical Stereotactic Radiotherapy (SRT) Versus Surgically Targeted Radiation Therapy (…
S2303 PARAMMUNE: Randomized Phase II/III Trial of 2nd Line Nivolumab + Paclitaxel + Ramucirumab Versus Paclitaxel + Ramucirumab in Patients With PD-…